Eric Daar
Infectious Disease · Torrance, CANPI 1336119676
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $61,371 of the $71,741 with a category attached, or 85.5%. 15 manufacturers reported payments, led by Gilead at 59.6% of the total. 2025 is the largest year on record at $20,708, 2.4 times the $8,795 reported in 2019. Among infectious disease clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $465.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$43K
- Merck$11K
- Viiv Healthcare Company$6K
- Shionogi Inc$3K
- Genentech, Inc.$3K
- Theratechnologies Inc.$3K
- plus $3K from 9 others
Across 182 payments — averaging $5146.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$764K
- Viiv Healthcare Company$169K
- Merck$4K
What the payments were for
- Consulting fees$61,37186%
- Speaking & faculty fees$3,6825%
- Grants$1,6102%
- Travel & lodging$1,7162%
- Food & beverage$3,3625%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 32 | $42,763 |
| Merck | 46 | $11,359 |
| Viiv Healthcare Company | 18 | $6,023 |
| Shionogi Inc | 26 | $3,486 |
| Genentech, Inc. | 1 | $2,993 |
| Theratechnologies Inc. | 2 | $2,500 |
| Janssen Scientific Affairs, LLC | 1 | $1,610 |
| Johnson & Johnson(2 entities) | 4 | $523 |
| Paratek Pharmaceuticals, Inc. | 9 | $161 |
| Astellas Pharma US Inc | 3 | $94 |
| Melinta Therapeutics, LLC | 5 | $90 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $45 |
| Heartflow, Inc. | 1 | $40 |
| Mylan Specialty L.p. | 2 | $29 |
| AbbVie | 2 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$71,741 in reported general payments places this provider in the 95th percentile of 856 infectious disease providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Torrance
- James McKinnellTorrance$762K
- Behzad NoorianTorrance$120K
- Claire PomeroySacramento$2.6M
- Javeed SiddiquiRoseville$1.5M
- George SakoulasSan Diego$902K
- Arthur JengSylmar$766K
- Jay GladsteinLos Angeles$657K
- Tulika SinghOrange$654K
- Otto YangLos Angeles$472K
- Franco FelizartaBakersfield$440K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.